Skip to main content

Table 1 Demographics and clinical characteristics of recruited COVID-19 patients

From: Prolonged viral shedding of SARS-CoV-2 and related factors in symptomatic COVID-19 patients: a prospective study

Characteristics

Total

Mild

Severe

P value

(n = 703)

(n = 616)

(n = 87)

Age, years, median (IQR)

63 (50–70)

62 (49–69)

67 (57–76)

 < 0.001

 ≤ 60

307 (43.7)

281 (45.6)

26 (29.9)

0.006*

 > 60

396 (56.3)

335 (54.4)

61 (70.1)

 

Sex, male, n (%)

332 (47.2)

281 (45.6)

51 (58.6)

0.023*

Interval#, days, median (IQR)

11 (7–15)

11 (7–15)

10 (7–15)

0.808

 ≤ 10

348 (49.5)

303 (49.2)

45 (51.7)

0.658

 > 10

355 (50.5)

313 (50.8)

42 (48.3)

 

Length of stay, days, median (IQR)

21 (14–24)

22 (15–24)

18 (10–23)

0.001

Clinical manifestation on admission, n (%)

    

 Fever

533 (75.8)

467 (75.8)

66 (75.9)

0.992

 Cough

438 (62.3)

387 (62.8)

51 (58.6)

0.449

 Fatigue

174 (24.8)

149 (24.2)

25 (28.7)

0.358

 Anhelation

178 (25.3)

149 (24.2)

29 (33.3)

0.066

 Nausea

57 (8.1)

50 (8.1)

7 (8.0)

0.982

 Diarrhea

115 (16.4)

104 (16.9)

11 (12.6)

0.317

 Anorexia

72 (10.2)

65 (10.6)

7 (8.0)

0.471

Comorbidity, n (%)

290 (41.3)

245 (39.8)

45 (51.7)

0.034

 Hypertension

236 (33.6)

199 (32.3)

37 (42.5)

0.059

 Diabetes

99 (14.1)

83 (13.5)

16 (18.4)

0.217

 Cardiovascular disease

53 (7.5)

47 (7.6)

6 (6.9)

0.808

 Cerebral infarction

19 (2.7)

15 (2.4)

4 (4.6)

0.417

  1. IQR interquartile range
  2. *Significant difference between mild and severe patients after adjusting for age, sex and presence of comorbidity
  3. #Indicates interval between disease onset and hospital admission